These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 19540055

  • 21. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 22. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
    Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1369-77. PubMed ID: 15050312
    [Abstract] [Full Text] [Related]

  • 23. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
    Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1106-12. PubMed ID: 15519781
    [Abstract] [Full Text] [Related]

  • 24. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J, Pang QS, Wang P, Wang J, Wang W.
    Zhonghua Zhong Liu Za Zhi; 2007 Oct 15; 29(10):769-72. PubMed ID: 18396691
    [Abstract] [Full Text] [Related]

  • 25. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G, Ruby E, Góhér I, Gábor G, Mohos A, Lengyel M.
    Orv Hetil; 2005 Jul 03; 146(27):1433-8. PubMed ID: 16089103
    [Abstract] [Full Text] [Related]

  • 26. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA, McGinnis WL, Stella PJ, Marschke RF, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA.
    Cancer; 1998 Mar 15; 82(6):1037-48. PubMed ID: 9506347
    [Abstract] [Full Text] [Related]

  • 27. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T, Mizutani Y, Ohmori T, Ishida H, Hosaka T, Ando K, Shirai T, Okuda K, Ohnishi T, Horichi N, Kubota H, Adachi M.
    Cancer Chemother Pharmacol; 2006 Sep 15; 58(3):361-7. PubMed ID: 16331494
    [Abstract] [Full Text] [Related]

  • 28. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
    Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara D.
    J Clin Oncol; 2007 Jan 20; 25(3):313-8. PubMed ID: 17235046
    [Abstract] [Full Text] [Related]

  • 29. Analysis of a novel protocol of combined induction chemotherapy and concurrent chemoradiation in unresected non-small-cell lung cancer: a ten-year experience with vinblastine, Cisplatin, and radiation therapy.
    Waters E, Dingle B, Rodrigues G, Vincent M, Ash R, Dar R, Inculet R, Kocha W, Malthaner R, Sanatani M, Stitt L, Yaremko B, Younus J, Yu E.
    Clin Lung Cancer; 2010 Jul 01; 11(4):243-50. PubMed ID: 20630826
    [Abstract] [Full Text] [Related]

  • 30. Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy.
    Jeong SH, Jung JH, Han JH, Kim JH, Choi YW, Lee HW, Kang SY, Hwang YH, Ahn MS, Choi JH, Oh YT, Chun M, Kang S, Park KJ, Hwang SC, Sheen SS.
    Lung Cancer; 2010 May 01; 68(2):288-94. PubMed ID: 19560836
    [Abstract] [Full Text] [Related]

  • 31. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):537-44. PubMed ID: 9336129
    [Abstract] [Full Text] [Related]

  • 32. [Induction chemotherapy followed by concomitant combined radiotherapy and chemotherapy in stage III non-small cell bronchial carcinoma].
    Bouillet T, Morère JF, Mazeron JJ, Piperno-Neuman S, Boaziz C, Haddad E, Breau JL.
    Cancer Radiother; 1997 Oct 01; 1(2):121-31. PubMed ID: 9273182
    [Abstract] [Full Text] [Related]

  • 33. Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.
    Holgersson G, Bergström S, Bergqvist M, Nyman J, Hoye E, Helsing M, Friesland S, Holgersson M, Birath E, Ekman S, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R.
    Eur J Cancer; 2011 Nov 01; 47(16):2415-21. PubMed ID: 21726999
    [Abstract] [Full Text] [Related]

  • 34. The impact of induction chemotherapy on the dosimetric parameters of subsequent radiotherapy: an investigation of 30 consecutive patients with locally-advanced non-small cell lung cancer and modern radiation planning techniques.
    Grant JD, Sobremonte A, Hillebrandt E, Allen PK, Gomez DR.
    Radiat Oncol; 2015 Jan 31; 10():32. PubMed ID: 25636372
    [Abstract] [Full Text] [Related]

  • 35. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
    Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler MJ, Abrams RA, Bonomi P, Liptay M, Faber LP.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):985-91. PubMed ID: 20932684
    [Abstract] [Full Text] [Related]

  • 36. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
    Wang L, Correa CR, Zhao L, Hayman J, Kalemkerian GP, Lyons S, Cease K, Brenner D, Kong FM.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1383-90. PubMed ID: 18929449
    [Abstract] [Full Text] [Related]

  • 37. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
    Lee YY, Choi CH, Kim CJ, Song TJ, Kim MK, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    Gynecol Oncol; 2010 Mar 01; 116(3):459-63. PubMed ID: 20004008
    [Abstract] [Full Text] [Related]

  • 38. Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.
    O'Day SJ, Boasberg PD, Piro L, Kristedja TS, Wang HJ, Martin M, Deck R, Ames P, Shinn K, Kim H, Fournier P, Gammon G.
    Clin Cancer Res; 2002 Sep 01; 8(9):2775-81. PubMed ID: 12231516
    [Abstract] [Full Text] [Related]

  • 39. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
    Yoon DH, Cho Y, Kim SY, Nam SY, Choi SH, Roh JL, Lee SW, Song SY, Lee JH, Kim JS, Cho KJ, Kim SB.
    Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):118-25. PubMed ID: 20675065
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of complete response in patients with muscle-invasive bladder cancer undergoing concurrent chemoradiotherapy.
    Wu CE, Lin YC, Hong JH, Chuang CK, Pang ST, Liaw CC.
    Anticancer Res; 2013 Jun 01; 33(6):2605-10. PubMed ID: 23749915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.